Status:
RECRUITING
WatchWell: Simple and Practical Strategies to Reduce the Negative Health Impact of Sedentary Screen Time
Lead Sponsor:
Arizona State University
Conditions:
Sedentary Time
Cardiovascular Diseases
Eligibility:
All Genders
26+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine the feasibility, acceptability, efficacy, and participant adherence in using home-based technologies and wearable devices and simple, practical strategies to ...
Detailed Description
Sedentary screen time (SST) is the most common discretionary activity among all US age and race/ethnic groups. SST is associated with poor health outcomes, including cardiovascular disease (CVD). Recr...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- ≥26 years of age
- BMI ≥ 27 kg/m2\*; ≥25 kg/m2, if Asian (full or multiple race)\*\*
- Insufficiently active (per US National Guidelines for Physical Activity of 150 minutes of MVPA/Week)
- Reporting an average of ≥3 hours of recreational sedentary screen time (rSST) per day, that usually extends at least until 9:00pm.
- On a typical night, consumes calories (food and/or drink) after 8:00pm.
- Meet at least 2 criteria for metabolic syndrome
- Central adiposity: waist circumference \>40 inches (men); \>35 inches (women)
- Elevated blood pressure: SBP \>130 mmHg and/or DBP \>85 mmHg OR controlled with medication
- Low high density lipoprotein (HDL) cholesterol: \<40 mg/dL (men); \<50 mg/dL (women)
- Elevated triglycerides: \>150 mg/dL OR controlled with medication
- Elevated fasting glucose: ≥100 mg/dL OR controlled with medication
- Exclusion Criteria
- Conditions related to sleep disruption, including lactation, pregnancy, mid-night care providers, sleep disorders, severe sleep apnea
- History of hypoglycemia
- Pacemaker
- Caffeine consumption in excess and/or after 5pm (excess equals \>4 cups of coffee per day or equivalent)
- Involvement in other physical activity, diet, or weight loss programs/studies
- Weight change of 5% up or down in the last three months.
- Drug abuse
- THC use (smoking, edibles)
- Excessive alcohol use (for women, 8 or more drinks per week; for men, 15 or more drinks per week)
- Current smoker or user of any nicotine source - any amount or form (vapor/e-cig/tobacco/patch, gum, etc.)
- Medications that markedly impact glucose metabolism and sleep (insulin, corticosteroids, growth hormone, melatonin)
- Previous or current diagnosis of a clinical eating disorder (e.g., night eating syndrome, anorexia, bulimia, binge eating disorder); or self-report eating disorder behaviors
- Unstable or poorly controlled blood glucose (e.g., hypoglycemia, fasting glucose greater than 125 mg/dL)
- Chronic illness that may be associated with weight change (HIV/AIDS, active cancer, or uncontrolled thyroid disease)
- Shift work
- Recent or upcoming jetlag (travel 3 months prior and during study that is \>1 time zone away from Arizona)
- Current practice of evening and nighttime blue light blocking.
- Poorly controlled hypertension (SBP ≥165 or DBP ≥100)
- Any condition or circumstance that would prevent compliance to the protocol
- Use non-android phone as their primary/personal phone
Exclusion
Key Trial Info
Start Date :
August 7 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06963736
Start Date
August 7 2025
End Date
December 31 2025
Last Update
August 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Arizona State University
Tempe, Arizona, United States, 85281